Internet of Nanothings (IoNT) and Machine Learning (ML) – Innovations in drug discovery and Healthcare system
1 Department of Pharmaceutics, College of Pharmacy, Madurai Medical College, Madurai-20. Affiliated to The Tamilnadu Dr.M.G.R. Medical University, Chennai-32, Tamilnadu.
2 Department of Computer science, University of Texas, El Paso, USA
Review
International Journal of Frontiers in Science and Technology Research, 2022, 02(01), 001–008.
Article DOI: 10.53294/ijfstr.2022.2.1.0021
Publication history:
Received on 06 December 2021; revised on 12 January 2022; accepted on 14 January 2022
Abstract:
The IoNT offers a medium to connect various nanodevices with the help of high speed networks. Using this technology nanodevices can be deployed along with other advanced technologies such as cloud computing, big data and ML. Many tedious tasks can be taken over by linked inanimate objects and better availability of information using IoNT-ML. This technology has shown great promise in improving efficiencies across numerous pharmaceutical and healthcare industries with high quality and vast datasets. It has the potential to foster innovation while simultaneously improving productivity and delivering better outcomes across the value chain. IoNT-ML can significantly improve the value proportion of pharmaceutical companies by driving innovation and the creation of new business models. This technology can be implemented in almost every aspect of the pharmaceutical industry, right from the drug discovery and development to manufacturing and marketing. This review discusses the principle of ML and its various applications in healthcare sector.
Keywords:
Internet of Nanothings; Machine Learning; Artificial Intelligence; Applications
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0